Recently, Deebio reached a strategic cooperation with MEDISCA, a global pharmaceutical compounding company. Deebio will Exclusively supply thyroid API to Medisca in compliance with FDA regulations. Through this cooperation, The unstable and inconsistent supply will be positively improved in the US market.
In order to meet MEDISCA's demands for transparency, quality and commitment to the market. Deebio built a new state-of-the-art manufacturing workshop for thyroid. The production process has the advantages of fully enclosed and highly automated. Which implements all of the technology and quality control procedures essential to conducting manufacturing activities in compliance with FDA cGMP.
Sichuan Deebiotech Co., Ltd is a global advanced bio-enzyme manufacturer with strong R&D capability. We are also an EUGMP and Chinese GMP certified company since 2005 and manufacturing enzymes with high activity, high purity and high stability. Our products have been exported to over 30 countries and regions such as Europe, North America, Japan and South Korea for more than 20 years! Deebiotech is also the long-term partner of Sanofi, Abbott and Novartis.
The subsidiary company Deebio Pharmaceutical is a company in China and also one of the few companies in the world that with the capability to produce thyroid API that meets FDA requirements. It all depends on Deebio's the constant dedication to the quality and the production process.
MEDISCA is a leader in providing complete solutions to the global pharmaceutical compounding industry and related healthcare professionals. Through its global partners LP3 network and MEDISCA network, MEDISCA is committed to providing complete resources for prescribers, pharmacists and pharmaceutical technicians engaged in personalized medicine by providing education, training, products and support. The company was established in 1989 and has branches in Canada, the United States and Australia to provide services in the global market.
Post time: Jun-24-2021
